{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:02:17Z","timestamp":1780142537515,"version":"3.54.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,30]]},"DOI":"10.7759\/cureus.109918","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:19:58Z","timestamp":1780139998000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unclassifiable Malignant Ovarian Germ Cell Tumor With Focal Choriocarcinoma-Like Features: A Case Report With Diagnostic Ambiguity and Adjuvant Treatment Considerations"],"prefix":"10.7759","author":[{"given":"Tadahisa","family":"Takeuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hachidai","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kusaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000913","article-title":"Molecular evidence for epithelial origin of mixed ovarian epithelial-germ cell neoplasms: report of 2 cases and review of literature","volume":"42","author":"Hall KC","year":"2023","unstructured":"Hall KC, Post MD, Alldredge J, Aisner DL, Berning A. Molecular evidence for epithelial origin of mixed ovarian epithelial-germ cell neoplasms: report of 2 cases and review of literature. Int J Gynecol Pathol. 2023, 42:403-13. 10.1097\/PGP.0000000000000913","journal-title":"Int J Gynecol Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.8738","article-title":"Management of ovarian germ cell tumors","volume":"25","author":"Gershenson DM","year":"2007","unstructured":"Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007, 25:2938-43. 10.1200\/JCO.2007.10.8738","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jog.70124","article-title":"Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: annual patient report for 2022 and annual treatment report for 2017","volume":"51","author":"Kajiyama H","year":"2025","unstructured":"Kajiyama H, Tamauchi S, Takahashi F, Satoh T. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: annual patient report for 2022 and annual treatment report for 2017. J Obstet Gynaecol Res. 2025, 51:10.1111\/jog.70124","journal-title":"J Obstet Gynaecol Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000223","article-title":"Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors","volume":"24","author":"Brown J","year":"2014","unstructured":"Brown J, Friedlander M, Backes FJ, et al.. Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors. Int J Gynecol Cancer. 2014, 24:48-54. 10.1097\/IGC.0000000000000223","journal-title":"Int J Gynecol Cancer"},{"key":"ref5","article-title":"Germ cell tumours","year":"2020","unstructured":"Germ cell tumours. Female Genital Tumours. WHO Classification of Tumours. Fifth Edition. International Agency for Research on Cancer, Lyon, France; 2020. 119-31."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw563","article-title":"The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study","volume":"28","author":"Mangili G","year":"2017","unstructured":"Mangili G, Sigismondi C, Lorusso D, et al.. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study. Ann Oncol. 2017, 28:333-8. 10.1093\/annonc\/mdw563","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-002575","article-title":"Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study","volume":"31","author":"Mangili G","year":"2021","unstructured":"Mangili G, Giorda G, Ferrandina G, et al.. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study. Int J Gynecol Cancer. 2021, 31:1242-7. 10.1136\/ijgc-2021-002575","journal-title":"Int J Gynecol Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy001","article-title":"Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Ray-Coquard I","year":"2018","unstructured":"Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, Colombo N. Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018, 29:1-18. 10.1093\/annonc\/mdy001","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000702","article-title":"Outcomes of surgery alone and surveillance strategy in young women with stage I malignant ovarian germ cell tumors","volume":"26","author":"Park JY","year":"2016","unstructured":"Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH. Outcomes of surgery alone and surveillance strategy in young women with stage I malignant ovarian germ cell tumors. Int J Gynecol Cancer. 2016, 26:859-64. 10.1097\/IGC.0000000000000702","journal-title":"Int J Gynecol Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1330481","article-title":"Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy","volume":"14","author":"Marino G","year":"2024","unstructured":"Marino G, Grassi T, De Ponti E, et al.. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy. Front Oncol. 2024, 14:10.3389\/fonc.2024.1330481","journal-title":"Front Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel M","year":"2016","unstructured":"K\u00f6bel M, Rahimi K, Rambau PF, et al.. An immunohistochemical algorithm for ovarian carcinoma typing. Int J Gynecol Pathol. 2016, 35:430-41. 10.1097\/PGP.0000000000000274","journal-title":"Int J Gynecol Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat J","year":"2014","unstructured":"Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014, 124:1-5. 10.1016\/j.ijgo.2013.10.001","journal-title":"Int J Gynaecol Obstet"},{"key":"ref13","unstructured":"NCCN Guidelines. Accessed. May 11, 2026: https:\/\/www.nccn.org\/guidelines\/guidelines-detail."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.07.044","article-title":"Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group","volume":"95","author":"Williams SD","year":"2004","unstructured":"Williams SD, Kauderer J, Burnett AF, Lentz SS, Aghajanian C, Armstrong DK. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group. Gynecol Oncol. 2004, 95:496-9. 10.1016\/j.ygyno.2004.07.044","journal-title":"Gynecol Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2024-005280","article-title":"Comparison of overall and patterns of care in patients with a malignant ovarian germ cell tumor by age in the United States: a National Cancer Database (2004-2016) analysis","volume":"34","author":"Sullivan SM","year":"2024","unstructured":"Sullivan SM, Stoneham S, Lockley M, Frazier AL, Billmire DF, Poynter JN. Comparison of overall and patterns of care in patients with a malignant ovarian germ cell tumor by age in the United States: a National Cancer Database (2004-2016) analysis. Int J Gynecol Cancer. 2024, 34:1906-13. 10.1136\/ijgc-2024-005280","journal-title":"Int J Gynecol Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/483031-an-unclassifiable-malignant-ovarian-germ-cell-tumor-with-focal-choriocarcinoma-like-features-a-case-report-with-diagnostic-ambiguity-and-adjuvant-treatment-considerations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:19:59Z","timestamp":1780139999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/483031-an-unclassifiable-malignant-ovarian-germ-cell-tumor-with-focal-choriocarcinoma-like-features-a-case-report-with-diagnostic-ambiguity-and-adjuvant-treatment-considerations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.109918","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,30]]}}}